what are the Recommendations for Anticoagulation for AF in Patients With VHD
Referenced studies that support the recommendations are
summarized in Online Data Supplement 2.?
F or patients with AF and native valve heart disease (except rheumatic mitral stenosis [MS]) or who received a bioprosthetic valve >3 months ago, a non?vitamin K oral anticoagulant (NOAC) is an effective alternative to VKA anticoagulation and should be administered on the basis of the patient?s CHADS-VASc score.1,2 2